Patient-Friendly Explanation

Topiramate is a medication originally developed for epilepsy and migraines that has been found to help with weight loss. It works by reducing appetite and making food taste less appealing, helping you eat less without feeling deprived.

Clinical Definition

Topiramate is a sulphamate-substituted monosaccharide anticonvulsant that promotes weight loss through multiple mechanisms: carbonic anhydrase inhibition, glutamate receptor (AMPA/kainate) antagonism, and GABA-A receptor potentiation. It is approved in combination with phentermine (Qsymia) for chronic weight management, demonstrating 8–10% mean body weight reduction in clinical trials.

Why It Matters

As a component of combination pharmacotherapy (Qsymia), topiramate offers an effective option for patients who have not achieved sufficient weight loss with lifestyle modification alone. Its unique mechanism complements other weight loss medications, allowing for personalised treatment strategies under medical supervision.